340B Manufacturer Audits Ramping Up In 2015

HRSA has launched only one audit of a drug manufacturer for compliance with 340B drug pricing requirements, and that is still ongoing, but the agency plans additional audits in 2015.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America